Bottom line
Is PABD a good fund? The bottom line
PABD is an index international stock ETF from iShares.
Its expense ratio is 0.12% — about $12 a year on every $10,000 invested, cheaper than 95% of international stock funds we track.
With $325 million in net assets and 443 holdings, its largest position is ASML Holding N.V. (2.9%) and the top 10 make up 14.9% of the portfolio.
The closest lower-cost alternative we found is SCHF (0.03%, 55% top-holdings overlap).
What stands out
- Low cost: cheaper than 95% of international stock peers
- Broadly diversified (443 holdings)
Updated Nov 19, 2026
What PABD invests in
The iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF (the Fund ) seeks to track the investment results of an index composed of large- and mid-capitalization developed market equities, excluding the U.S., that is designed to be compatible with the objectives of the Paris Agreement by, in aggregate, following a decarbonization trajectory, reducing exposure to climate-related transition and physical risks and increasing exposure to companies favorably positioned for the transition to a low-carbon economy.
The Fund seeks to track the investment results of the MSCI World ex USA Climate Paris Aligned Benchmark Extended Select Index (the Underlying Index ), which has been developed by MSCI Inc. (the Index Provider or MSCI ). The Underlying Index is composed of large- and mid-capitalization developed market equities, excluding the U.S., that are selected and weighted so that, in the aggregate, the portfolio is compatible with the objectives of the Paris Agreement by following a decarbonization trajectory, reducing exposure to climate-related transition and physical risks and increasing exposure to companies favorably positioned for the transition to a low-carbon economy. The Underlying Index aims to exceed the minimum standards for a Paris-Aligned Benchmark ( PAB ) under the European Unions Low Carbon Benchmark Regulation. PABs are designed to align with the principal objective of the Paris…
From the fund's prospectus (filed Dec 19, 2025).
What PABD costs
On a $10,000 investment, PABD's 0.12% expense ratio costs about $12 a year. The prospectus estimates $154 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
PABD top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding N.V. | 2.91% |
| 2 | Novartis AG | 1.48% |
| 3 | Royal Bank Of Canada | 1.47% |
| 4 | Hsbc Holdings Plc | 1.42% |
| 5 | ABB Ltd | 1.40% |
| 6 | Roche Holding AG | 1.34% |
| 7 | Astrazeneca Plc | 1.31% |
| 8 | Schneider Electric Se | 1.28% |
| 9 | Murata Manufacturing Co., Ltd. | 1.21% |
| 10 | The Toronto-dominion Bank | 1.06% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 14.9% of the fund. See all top 25 holdings and asset mix →
Alternatives to PABD
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| Schwab | SCHF Schwab International Equity ETF | 0.03% | 55% | Compare |
| Fidelity | FSPSX Fidelity International Index Fund | 0.035% | 68% | Compare |
| J.P. Morgan | BBIN JPMorgan BetaBuilders International… | 0.07% | 64% | Compare |
| SPDR (State Street) | EFAX State Street(R) SPDR(R) MSCI EAFE… | 0.2% | 66% | Compare |
| T. Rowe Price | PIEQX T. Rowe Price International Equity… | 0.25% | 59% | Compare |